News & Articles
Selected Filters:
Pfizer issues five-point plan to tackle COVID-19
Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic
Bio-Rad launches SARS CoV-2 Standard for COVID-19 testing
The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA
A new solution to efficiently manage your biorepository and maintain high-quality data
Register for this webinar to learn more about STARLIMS and how it can be used to suport the entire life-cycle of your samples
Arthritis drug Kevzara to treat patients with severe COVID-19 in global trial program
Seeking a shortcut to treatment for the novel coronavirus pandemic, Sanofi and Regeneron will roll out phase 2/3 trials of the arthritis drug
QIAGEN gains funding for approval process of QIAstat-Dx test kit for COVID-19
The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes
IDT achieves large-scale manufacturing success of key COVID-19 test component
IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19
Best practices for choosing a method for single-cell genomic analysis
Join this webinar with Dr. Maurizio Morri, Chan Zuckerberg Biohub, for insight on how to choose the right technique for your study
Thermo Fisher Scientific COVID-19 diagnostic test gets FDA emergency use authorization
The FDA has issued its fourth Emergency Use Authorization for coronavirus tests, this time to Thermo Fisher Scientific for its TaqPath COVID-19 Combo Kit
Roche secures FDA emergency use authorization for its coronavirus test
The first commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs
Analytica postponed due to coronavirus concerns
Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020
Ellutia presents failsafe total nitrosamine testing in pharmaceuticals at Pittcon 2020
Ellutia is presenting its nitrosamine testing solution for pharmaceuticals using its 800 Series Thermal Energy Analyser with Chemical Stripping System
Agilent's SureSelect DNA kit to accelerate capture-based enrichment library preparation
The new kit promises enhanced performance and flexibility to power cancer and genetics research
Abbott introduces next-generation heart rhythm management devices in Europe
New Gallant high-voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity
Avacta’s proprietary TMAC cancer therapy platform demonstrates successful proof-of-concept in pre-clinical study
Positive in vivo efficacy and pharmacokinetic data shows AVA04-VbP drug conjugate out-performed Bavencio immunotherapy
Experience convenient sample storage with the Verso Q20 Automated Sample Storage System
Free yourself from the time-consuming burden of picking sample tubes and embrace a fresh, new perspective
TTP Labtech announces company name change to SPT Labtech
The change of name is a contractual requirement of its divestment from TTP Group in 2018 with the backing of technology-focused investment firm Battery Ventures
IONTAS antibody enters clinical trials
The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia
Smart tags on pills set to improve supply chain security and patient adherence
PWC-Colorcon-TruTag technology coalition prove out the mass digitalization of pharma pills
Catalyzing development of therapies through collaborations
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
Cryogenic tubes for sample storage at ultra-low temperatures
The Ziath range of CryzoTraq™ 2D-barcoded tubes aims to set a new standard for cryogenic storage of biological specimens at temperatures as low as -196°C
Prokarium announces MHRA acceptance to run phase I trial of lead vaccine against enteric fever
Clinical trial will evaluate the safety and immunogenicity of Entervax™
Clinical development behind a novel chimeric antigen receptor T-cell therapy - on demand webinar
Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies